Say on Pay votes and director elections that failed or nearly failed, and stockholder proposals that passed or came closest to passing. Each list is sorted by distance from the pass/fail line rather than a fixed cutoff — the notable cases sit at the top.
Vote results sourced from 8-K Item 5.07 filings. Results are informational only and do not constitute investment advice or a proxy solicitation.
Sorted by lowest support first — failed votes lead, near-misses follow.
Showing 30 of 30 rows.
Sorted by lowest support first — failed nominees lead, closest calls follow.
| Company | Nominee | % For | Result |
|---|---|---|---|
| UNF — UNIFIRST CORP | Arnaud Ajdler | 19.4% | Failed election |
| UNF — UNIFIRST CORP | Michael A. Croatti | 20.1% | Failed election |
| Closest calls below | |||
| TGTX — TG THERAPEUTICS INC | Sagar Lonial, MD | 54.1% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Athena Countouriotis, M.D. | 56.6% | Elected |
| KROS — KEROS THERAPEUTICS INC | Mary Ann Gray, Ph.D. | 57.8% | Elected |
| TGTX — TG THERAPEUTICS INC | Yann Echelard | 58.6% | Elected |
| TGTX — TG THERAPEUTICS INC | Daniel Hume | 58.9% | Elected |
| TGTX — TG THERAPEUTICS INC | Kenneth Hoberman | 60.5% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Michael G. Raab | 60.9% | Elected |
| KROS — KEROS THERAPEUTICS INC | Alpna Seth, Ph.D. | 63.6% | Elected |
| TSLA — TESLA INC | Ira Ehrenpreis | 65.0% | Elected |
| NTRA — NATERA INC | Gail Marcus | 70.8% | Elected |
| GH — GUARDANT HEALTH INC | Musa Tariq | 71.3% | Elected |
| ORCL — ORACLE CORP | Bruce R. Chizen | 76.1% | Elected |
| AXON — AXON ENTERPRISE INC | Hadi Partovi | 76.8% | Elected |
| UNF — UNIFIRST CORP | Joseph M. Nowicki | 78.0% | Elected |
| TSLA — TESLA INC | Kathleen Wilson-Thompson | 78.4% | Elected |
| UNF — UNIFIRST CORP | Steven S. Sintros | 79.5% | Elected |
| TGTX — TG THERAPEUTICS INC | Laurence N. Charney | 80.6% | Elected |
| NTRA — NATERA INC | Roy Baynes | 80.9% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Thilo Schroeder, Ph.D. | 80.9% | Elected |
| KROS — KEROS THERAPEUTICS INC | Ran Nussbaum | 81.1% | Elected |
| SLGN — SILGAN HOLDINGS INC | Brad A. Lich | 81.6% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Iain Dukes, D. Phil. | 82.2% | Elected |
| ORCL — ORACLE CORP | Awo Ablo | 83.9% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Sushil Patel, Ph.D. | 85.5% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Sandra J. Horning, M.D. | 85.5% | Elected |
| TGTX — TG THERAPEUTICS INC | Michael S. Weiss | 85.5% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Mark Fishman, M.D. | 85.8% | Elected |
| ALGM — ALLEGRO MICROSYSTEMS INC | Yoshihiro (Zen) Suzuki | 85.8% | Elected |
| ATEX — ANTERIX INC | Leslie B. Daniels | 86.0% | Elected |
| TSLA — TESLA INC | Joe Gebbia | 87.3% | Elected |
| DXCM — DEXCOM INC | Nicholas Augustinos | 88.3% | Elected |
| ALGM — ALLEGRO MICROSYSTEMS INC | Katsumi Kawashima | 88.8% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Laura A. Brege | 89.0% | Elected |
| CSCO — CISCO SYSTEMS INC | Daniel H. Schulman | 90.6% | Elected |
| CSCO — CISCO SYSTEMS INC | Charles H. Robbins | 90.9% | Elected |
| ORCL — ORACLE CORP | Michael J. Boskin | 91.3% | Elected |
| KLAC — KLA CORP | Robert Calderoni | 91.4% | Elected |
| MSFT — MICROSOFT CORP | Hugh F. Johnston | 91.5% | Elected |
| ORCL — ORACLE CORP | Jeffrey O. Henley | 92.0% | Elected |
| CSCO — CISCO SYSTEMS INC | Michael D. Capellas | 92.0% | Elected |
| ORCL — ORACLE CORP | Jeffrey S. Berg | 92.2% | Elected |
| ORCL — ORACLE CORP | George H. Conrades | 92.3% | Elected |
| ORCL — ORACLE CORP | Naomi O. Seligman | 92.6% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Ted Love, M.D. | 92.9% | Elected |
| AXON — AXON ENTERPRISE INC | Julie Cullivan | 93.0% | Elected |
| JPM — JPMORGAN CHASE & CO | Stephen B. Burke | 93.0% | Elected |
| COST — COSTCO WHOLESALE CORP | Jeffrey S. Raikes | 93.2% | Elected |
| MSFT — MICROSOFT CORP | Satya Nadella | 93.5% | Elected |
| AXON — AXON ENTERPRISE INC | Michael Garnreiter | 93.6% | Elected |
| KLAC — KLA CORP | Kevin Kennedy | 93.8% | Elected |
| JPM — JPMORGAN CHASE & CO | James Dimon | 93.8% | Elected |
| MU — MICRON TECHNOLOGY INC | Richard M. Beyer | 93.8% | Elected |
| MU — MICRON TECHNOLOGY INC | Sanjay Mehrotra | 93.9% | Elected |
| AXON — AXON ENTERPRISE INC | Adriane Brown | 94.4% | Elected |
| ATEX — ANTERIX INC | Mahvash Yazdi | 94.4% | Elected |
| COST — COSTCO WHOLESALE CORP | Susan L. Decker | 94.6% | Elected |
| AXON — AXON ENTERPRISE INC | Graham Smith | 94.6% | Elected |
| COST — COSTCO WHOLESALE CORP | Maggie Wilderotter | 94.7% | Elected |
| DXCM — DEXCOM INC | Kevin R. Sayer | 94.9% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Pablo Legorreta | 95.0% | Elected |
| COST — COSTCO WHOLESALE CORP | Hamilton E. James | 95.0% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Frederick G. Vogt, Ph.D., J.D. | 95.1% | Elected |
| EXEL — EXELIXIS INC | Stelios Papadopoulos, Ph.D. | 95.1% | Elected |
| DXCM — DEXCOM INC | Bridgette P. Heller | 95.1% | Elected |
| MSFT — MICROSOFT CORP | Charles W. Scharf | 95.6% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Michael Weiser, M.D., Ph.D. | 95.6% | Elected |
| KLAC — KLA CORP | Michael McMullen | 95.7% | Elected |
| ATEX — ANTERIX INC | Jeffrey A. Altman | 96.1% | Elected |
| MU — MICRON TECHNOLOGY INC | MaryAnn Wright | 96.1% | Elected |
| PG — PROCTER & GAMBLE | Moeller, Jon R. | 96.1% | Elected |
| PG — PROCTER & GAMBLE | Kempczinski, Christopher | 96.2% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Ryan Maynard | 96.3% | Elected |
| PG — PROCTER & GAMBLE | McCarthy, Christine M. | 96.4% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Margaret G. McGlynn | 96.4% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Wayne P. Rothbaum | 96.5% | Elected |
| EXEL — EXELIXIS INC | Tomas J. Heyman | 96.5% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Elizabeth A. Garofalo, M.D. | 96.5% | Elected |
| MSFT — MICROSOFT CORP | Teri L. List | 96.6% | Elected |
| ORCL — ORACLE CORP | Lawrence J. Ellison | 96.7% | Elected |
| JPM — JPMORGAN CHASE & CO | Todd A. Combs | 96.7% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Wendy Yarno | 96.7% | Elected |
| MSFT — MICROSOFT CORP | Sandra E. Peterson | 96.8% | Elected |
| NTRA — NATERA INC | Ruth Williams-Brinkley | 96.8% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Curtis W. Huff | 96.8% | Elected |
| DXCM — DEXCOM INC | Steven R. Altman | 97.0% | Elected |
| CSCO — CISCO SYSTEMS INC | Dr. Kristina M. Johnson | 97.0% | Elected |
| EXEL — EXELIXIS INC | Jack L. Wyszomierski | 97.2% | Elected |
| ORCL — ORACLE CORP | Safra A. Catz | 97.3% | Elected |
| JPM — JPMORGAN CHASE & CO | Linda B. Bammann | 97.3% | Elected |
| GH — GUARDANT HEALTH INC | Vijaya Gadde | 97.4% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Glenn P. Sblendorio | 97.4% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Gregory Norden | 97.5% | Elected |
| CSCO — CISCO SYSTEMS INC | Mark Garrett | 97.6% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | David Hodgson | 97.6% | Elected |
| PG — PROCTER & GAMBLE | Jimenez, Joseph | 97.7% | Elected |
| MSFT — MICROSOFT CORP | John W. Stanton | 97.7% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Michael A. Kelly | 97.7% | Elected |
| ORCL — ORACLE CORP | Charles W. Moorman | 97.8% | Elected |
| DXCM — DEXCOM INC | Mark G. Foletta | 97.8% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Errol De Souza, Ph.D. | 98.0% | Elected |
| MU — MICRON TECHNOLOGY INC | Steven J. Gomo | 98.0% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Catherine Owen Adams | 98.0% | Elected |
| EXEL — EXELIXIS INC | Maria C. Freire, Ph.D. | 98.0% | Elected |
| PG — PROCTER & GAMBLE | Portman, Robert J. | 98.0% | Elected |
| COST — COSTCO WHOLESALE CORP | Helena B. Foulkes | 98.1% | Elected |
| GH — GUARDANT HEALTH INC | Myrtle Potter | 98.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Tiffany (TJ) Thom Cepak | 98.1% | Elected |
| PG — PROCTER & GAMBLE | Lee, Debra L. | 98.2% | Elected |
| PG — PROCTER & GAMBLE | Allen, B. Marc | 98.2% | Elected |
| NVCR — NOVOCURE LTD | Kinyip Gabriel Leung | 98.2% | Elected |
| EXEL — EXELIXIS INC | Mary C. Beckerle, Ph.D. | 98.2% | Elected |
| ORCL — ORACLE CORP | Clayton M. Magouyrk | 98.3% | Elected |
| ORCL — ORACLE CORP | Michael D. Sicilia | 98.3% | Elected |
| AXON — AXON ENTERPRISE INC | Matthew McBrady | 98.3% | Elected |
| DXCM — DEXCOM INC | Richard A. Collins | 98.3% | Elected |
| ATEX — ANTERIX INC | Thomas R. Kuhn | 98.3% | Elected |
| DXCM — DEXCOM INC | Kyle Malady | 98.3% | Elected |
| PG — PROCTER & GAMBLE | Biggs, Brett | 98.3% | Elected |
| ORCL — ORACLE CORP | Rona A. Fairhead | 98.4% | Elected |
| MU — MICRON TECHNOLOGY INC | Mary Pat McCarthy | 98.4% | Elected |
| PG — PROCTER & GAMBLE | Bonini, Sheila | 98.4% | Elected |
| AXON — AXON ENTERPRISE INC | Erika Ayers Badan | 98.4% | Elected |
| PG — PROCTER & GAMBLE | Subramaniam, Rajesh | 98.5% | Elected |
| PG — PROCTER & GAMBLE | Chang, Amy L. | 98.5% | Elected |
| COST — COSTCO WHOLESALE CORP | John W. Stanton | 98.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Mark A. Weinberger | 98.5% | Elected |
| ATEX — ANTERIX INC | Scott A. Lang | 98.5% | Elected |
| ATEX — ANTERIX INC | William E. Heard | 98.6% | Elected |
| MU — MICRON TECHNOLOGY INC | Lynn A. Dugle | 98.7% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | William A. Hendricks, Jr. | 98.7% | Elected |
| JPM — JPMORGAN CHASE & CO | Virginia M. Rometty | 98.7% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Gary M. Halverson | 98.7% | Elected |
| EXEL — EXELIXIS INC | Julie Anne Smith | 98.7% | Elected |
| EXEL — EXELIXIS INC | George Poste, DVM, Ph.D., FRS | 98.7% | Elected |
| NVCR — NOVOCURE LTD | William Vernon | 98.7% | Elected |
| COST — COSTCO WHOLESALE CORP | Kenneth D. Denman | 98.8% | Elected |
| GH — GUARDANT HEALTH INC | Roberto Mignone | 98.8% | Elected |
| ATEX — ANTERIX INC | Mark A. Fleischhauer | 98.8% | Elected |
| AXON — AXON ENTERPRISE INC | Caitlin Kalinowski | 98.8% | Elected |
| COST — COSTCO WHOLESALE CORP | Sally Jewell | 98.9% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Bonnie Bassler, Ph.D. | 98.9% | Elected |
| AXON — AXON ENTERPRISE INC | Jeri Williams | 98.9% | Elected |
| MU — MICRON TECHNOLOGY INC | Linnie M. Haynesworth | 99.0% | Elected |
| MSFT — MICROSOFT CORP | Mark A. L. Mason | 99.0% | Elected |
| EXEL — EXELIXIS INC | Michael M. Morrissey, Ph.D. | 99.0% | Elected |
| NVCR — NOVOCURE LTD | William Doyle | 99.0% | Elected |
| EXEL — EXELIXIS INC | Robert L. Oliver, Jr. | 99.0% | Elected |
| AXON — AXON ENTERPRISE INC | Patrick Smith | 99.1% | Elected |
| MSFT — MICROSOFT CORP | Reid G. Hoffman | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | James C. Stewart | 99.1% | Elected |
| NVCR — NOVOCURE LTD | Asaf Danziger | 99.1% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Henry Fernandez | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Leslie Beyer | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Amy H. Nelson | 99.2% | Elected |
| PG — PROCTER & GAMBLE | McEvoy, Ashley | 99.2% | Elected |
| PG — PROCTER & GAMBLE | Jejurikar, Shailesh | 99.2% | Elected |
| JPM — JPMORGAN CHASE & CO | Phebe N. Novakovic | 99.2% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Julie J. Robertson | 99.2% | Elected |
| PG — PROCTER & GAMBLE | Arnold, Craig | 99.2% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Catherine Engelbert | 99.2% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Carole Ho, M.D. | 99.2% | Elected |
| EXEL — EXELIXIS INC | S. Gail Eckhardt, M.D. | 99.3% | Elected |
| EXEL — EXELIXIS INC | David E. Johnson | 99.3% | Elected |
| CSCO — CISCO SYSTEMS INC | John D. Harris II | 99.3% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Janeen S. Judah | 99.3% | Elected |
| CSCO — CISCO SYSTEMS INC | Marianna Tessel | 99.3% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Robert W. Drummond | 99.3% | Elected |
| COST — COSTCO WHOLESALE CORP | Ron M. Vachris | 99.3% | Elected |
| NVCR — NOVOCURE LTD | David Hung | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Allyson Ocean | 99.4% | Elected |
| JPM — JPMORGAN CHASE & CO | Michele G. Buck | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Timothy Scannell | 99.4% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Cesar Jaime | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Jeryl Hilleman | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Martin Madden | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Kristin Stafford | 99.4% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Vlad Coric, M.D. | 99.4% | Elected |
| MSFT — MICROSOFT CORP | Emma N. Walmsley | 99.5% | Elected |
| MSFT — MICROSOFT CORP | Penny S. Pritzker | 99.5% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Kathleen Walsh | 99.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Alex Gorsky | 99.5% | Elected |
| MSFT — MICROSOFT CORP | Catherine MacGregor | 99.5% | Elected |
| MU — MICRON TECHNOLOGY INC | Robert Swan | 99.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Mellody Hobson | 99.5% | Elected |
| NVCR — NOVOCURE LTD | Ashley Cordova | 99.6% | Elected |
| JPM — JPMORGAN CHASE & CO | Alicia Boler Davis | 99.6% | Elected |
| KLAC — KLA CORP | Victor Peng | 99.6% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Frank K. Clyburn, Jr. | 99.7% | Elected |
| CSCO — CISCO SYSTEMS INC | Kevin Weil | 99.7% | Elected |
| KLAC — KLA CORP | Jamie Samath | 99.7% | Elected |
| KLAC — KLA CORP | Jason Conley | 99.7% | Elected |
| JPM — JPMORGAN CHASE & CO | Brad D. Smith | 99.7% | Elected |
| KLAC — KLA CORP | Jeneanne Hanley | 99.7% | Elected |
| MSFT — MICROSOFT CORP | John David Rainey | 99.7% | Elected |
| CSCO — CISCO SYSTEMS INC | Sarah Rae Murphy | 99.7% | Elected |
| SLGN — SILGAN HOLDINGS INC | Adam J. Greenlee | 99.7% | Elected |
| DXCM — DEXCOM INC | Rimma Driscoll | 99.8% | Elected |
| DXCM — DEXCOM INC | Renée Galá | 99.8% | Elected |
Showing 200 of 200 rows (capped at 200).
Sorted by highest support first — passed proposals lead, closest-to-passing failures follow. Board-proposed charter items are excluded.
| Company | Proposal | % For | Outcome | Filer |
|---|---|---|---|---|
| TSLA — TESLA INC | Elect Each Director Annually | 53.8% | passed | — |
| Closest-to-passing failures below | ||||
| TSLA — TESLA INC | Seek Shareholder Approval Before Adopting Amendment to Bylaws Pursuant to Section 21.373 of TBOC | 48.8% | failed | — |
| TSLA — TESLA INC | Board Authorization of an Investment in x.AI Corp | 43.3% | failed | Other / unidentified |
| JPM — JPMORGAN CHASE & CO | Proposal on support for an independent board chairman | 36.6% | failed | Individual activist |
| TSLA — TESLA INC | Proposal that Won 54% Support at 2024 Annual Meeting | 31.9% | failed | — |
| MSFT — MICROSOFT CORP | Report on data operations in human rights hotspots | 27.1% | failed | Other / unidentified |
| MSFT — MICROSOFT CORP | Report on human rights due diligence | 25.8% | failed | — |
| TSLA — TESLA INC | Amend Bylaws to Repeal 3% Derivative Suit Ownership Threshold | 24.8% | failed | Institutional / pension fund |
| V — VISA INC CLASS A | Shareholder proposal requesting adoption of a new director election resignation governance guideline: | 16.9% | failed | Other / unidentified |
| TSLA — TESLA INC | Amend Article X of the Bylaws | 15.3% | failed | — |
| PG — PROCTER & GAMBLE | Shareholder Proposal Requesting Additional Reporting on Plastic Packaging | 13.7% | failed | Ideological — progressive |
| V — VISA INC CLASS A | Shareholder proposal on transparency in lobbying: | 13.6% | failed | Ideological — progressive |
| MSFT — MICROSOFT CORP | Report on AI data usage oversight | 13.2% | failed | Ideological — conservative |
| JPM — JPMORGAN CHASE & CO | Proposal on report on social impacts of transition finance | 10.6% | failed | Ideological — progressive |
| TSLA — TESLA INC | Adopting Targets and Reporting on Metrics for Sustainability Metrics in Senior Executive Compensation | 8.8% | failed | Ideological — progressive |
| MSFT — MICROSOFT CORP | Report on AI and machine learning tools for oil and gas development and production | 8.6% | failed | — |
| TSLA — TESLA INC | Child Labor Audit | 7.6% | failed | Ideological — conservative |
| COST — COSTCO WHOLESALE CORP | Shareholder proposal requesting report on the risks of maintaining DEI efforts | 1.7% | failed | Ideological — conservative |
| CSCO — CISCO SYSTEMS INC | A stockholder proposal to request the Board to conduct an evaluation and issue a report assessing how Cisco's inclusion programs provide positive financial value to stockholders | 1.1% | failed | Ideological — conservative |
| MSFT — MICROSOFT CORP | European Security Program Censorship risk audit | 0.8% | failed | Ideological — conservative |
| V — VISA INC CLASS A | Shareholder proposal requesting a report on policy on merchant category codes: | 0.8% | failed | Other / unidentified |
| MSFT — MICROSOFT CORP | Report on risks of censorship in generative artificial intelligence | 0.7% | failed | Ideological — conservative |
Showing 22 of 22 rows.
